Drug Trial Radar · NCT04479852
A Study of the Safety and Efficacy of SP-624 in the Treatment of Adults With Major Depressive Disorder
Last checked: Nov 19, 2026Latest source record: Jun 12, 2025 (this record)Source: ClinicalTrials.govMethods & limitations
Status
Completed
Enrollment
319
Actual
Start
Sep 30, 2020
Primary completion
Jun 27, 2022
Study completion Aug 9, 2022
Sponsor
- Lead sponsor
- Sirtsei Pharmaceuticals, Inc.Industry
- Sponsor type
- Industry
- First posted
- Jul 21, 2020
Design
- Study type
- Interventional
- Phase
- Phase 2
- Allocation
- Randomized
- Model
- Parallel
- Masking
- Quadruple (participant, care provider, investigator, outcomes assessor)
- Primary purpose
- Treatment
- FDA-regulated drug
- Yes
- Who can join
- All sexes, from 18 years, up to 65 years
- Healthy volunteers
- No
Summary
As written by the sponsor on the registry.
This is a Phase 2 clinical study evaluating the safety and effectiveness of SP-624 as compared to placebo in the treatment of adults with Major Depressive Disorder.
Conditions
- Major Depressive Disorder
Interventions
SP-624Drug
Oral capsule
PlaceboDrug
Oral capsule
Primary outcomes
What the sponsor says the trial is designed to measure.
- Change From Baseline to Week 4 in Montgomery Asberg Depression Rating Scale (MADRS) Total ScoreTime frame: Baseline to Week 4
Locations
39 sites in 1 country. Site status is shown where the registry gives one.
Alea Research
Phoenix, Arizona
Woodland International Research Group
Little Rock, Arkansas
Woodland Research Northwest
Rogers, Arkansas
Collaborative Neuroscience Research
Garden Grove, California
Pacific Research Partners
Oakland, California
Artemis Institute for Clinical Research
San Diego, California
Collaborative Neuroscience Research
Torrance, California
MCB Clinical Research Centers
Colorado Springs, Colorado
Sarkis Clinical Trials
Gainesville, Florida
Clinical Neuroscience Solutions, Inc.
Jacksonville, Florida
Innovative Clinical Research
Lauderhill, Florida
Clinical Neuroscience Solutions, Inc.
Orlando, Florida
Institute for Advanced Medical Research
Alpharetta, Georgia
Atlanta Center for Medical Research
Atlanta, Georgia
iResearch Atlanta
Decatur, Georgia
American Medical Research
Chicago, Illinois
Capstone Clinical Research
Libertyville, Illinois
CBH Health
Gaithersburg, Maryland
Midwest Research Group
Saint Charles, Missouri
Altea Research Institute
Las Vegas, Nevada
Hassman Research Institute
Berlin, New Jersey
Center for Emotional Fitness
Cherry Hill, New Jersey
Hassman Research Institute
Marlton, New Jersey
SPRI Clinical Trials
Brooklyn, New York
Manhattan Behavioral Medicine
New York, New York
Richmond Behavioral Associates
Staten Island, New York
New Hope Clinical Research
Charlotte, North Carolina
Clinical Trials of America
Hickory, North Carolina
Midwest Clinical Research Center
Dayton, Ohio
Cutting Edge Research Group
Oklahoma City, Oklahoma
Oregon Center for Clinical Investigations
Portland, Oregon
Oregon Center for Clinical Investigations
Salem, Oregon
Lehigh Center for Clinical Research
Allentown, Pennsylvania
Clinical Neuroscience Solutions, Inc.
Memphis, Tennessee
Donald J. Garcia, Jr., MD, PA
Austin, Texas
Future Search Trials of Dallas
Dallas, Texas
Red Oak Psychiatry Associates
Houston, Texas
Grayline Research Center
Wichita Falls, Texas
Core Clinical Research
Everett, Washington
Contact details for sites and study staff are not shown here. To ask about taking part, use the contact information on the registry record.
For information only. Nothing on this page is investment, legal, tax or medical advice, and nothing here is an offer to sell or a solicitation of an offer to buy any security. The data comes from public government sources, which can be incomplete, delayed or wrong. Check the original record before relying on it.